Biosimilars and Biobetters

Latest News

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Celltrion Gains Expanded Indication Approval from FDA for its Actemra Biosimilar for CRS Therapy

August 9th 2025

The additional approval expands the label for Avtozma (tocilizumab-anoh) to now include the treatment of cytokine release syndrome, which aligns the therapy with all indications for which Actemra is approved in the US.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
Polpharma Biologics, Fresenius Kabi Enter Licensing Agreement for Proposed Biosimilar to Takeda’s Entyvio

August 6th 2025

two vaccine mockup balance on a swing | Image Credit: ©petrovk – stock.adobe.com
The Evolving Cost-Benefit Landscape of Biosimilar Drug Development

June 17th 2025

Healthcare professional checks a digital checklist using advanced technology, emphasizing efficiency and accuracy in modern medical systems | Image Credit: © ACHJIMA - stock.adobe.com
Biocon’s Ustekinumab Biosimilar Gets MHRA Approval

May 29th 2025

row of medical bottles | Image Credit: ©petrovk – stock.adobe.com
The Challenge of Market Uptake for Biosimilars

May 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.